Alison Berndt
Family · Bel Air, MDNPI 1568834588
Payments from drug & device makers
Across 454 payments — averaging $24.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- AstraZeneca$1K
- Inspire Medical Systems, Inc.$1K
- Regeneron Healthcare Solutions, Inc.$876
- Jazz Pharmaceuticals Inc.$614
- Grifols USA, LLC$610
- plus $5K from 33 others
What the payments were for
- Travel & lodging$5795%
- Food & beverage$10,21792%
- Education$2572%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$813
- DUPIXENT$242
- Inspire Upper Airway Stimulation System$136
- BREZTRI$128
- AREXVY$126
How this compares
$11,053 in reported general payments places this provider in the 95th percentile of 2,843 family providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 357 | $369,502 |
| Breo ElliptaFluticasone/Vilanterol | 152 | $103,351 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 100 | $81,319 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 90 | $78,084 |
| Spiriva RespimatTiotropium Bromide | 82 | $59,191 |
| Arnuity ElliptaFluticasone Furoate | 78 | $22,483 |
| Incruse ElliptaUmeclidinium Bromide | 28 | $17,430 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 20 | $15,789 |
| Advair HfaFluticasone Propion/Salmeterol | 18 | $13,564 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 14 | $11,633 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 215 | $9,639 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 38 | $8,001 |
| SymbicortBudesonide/Formoterol Fumarate | 22 | $7,823 |
| DuleraMometasone/Formoterol | 21 | $6,748 |
| Roflumilast | 46 | $3,725 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta, Incruse Ellipta | $2,029 | $594,085715 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat, Combivent Respimat | $452 | $86,613116 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,314 | $85,907112 claims |
| MerckDulera | $17 | $6,74821 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,843 family providers in Maryland.
Other family in Bel Air
- Sharon Dudley-BrownBel Air$67K
- Robbin WitkowskiBel Air$9K
- Ariana ChaoLutherville$727K
- Erika HoffmanPotomac$226K
- Caroline MansySalisbury$106K
- Hazel Jones-ParkerBaltimore$96K
- Brittany WilsonBaltimore$88K
- Meredith SagalHunt Valley$82K
- Joy MaulikSalisbury$47K
- Kristin AttiogbeChevy Chase$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.